ProShares UltraShort Nasdaq Biotechnology (BIS)

NASDAQ: BISProSharesTrading--Inverse EquityETFUSD

11.53-0.6944 (-5.68%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

BIS chart

Key facts

Expense ratio: 0.95%
Assets (AUM): $1.85M
Dividend yield: 5.53%
Holdings: —
Inception: Apr 6, 2010
Issuer: ProShares
Index tracked: —
Category: Trading--Inverse Equity
52-week range: 10.51 – 24.54
Volume / Avg: 14.19K / 7.77K
Beta: —
Previous close: 12.22

BIS ETF today

The ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund from ProShares in the Trading--Inverse Equity category. It charges an expense ratio of 0.95%, or $95.00 per year on a $10,000 investment, and manages $1.9 million in assets. The fund's trailing dividend yield is 5.53% ($0.00 per share annually).

BIS launched on Apr 6, 2010.

Summary generated from market data by MetaCap's automated system. Methodology

BIS performance

1 week

-3.51%

BIS price return, excluding dividends.

ETFs similar to BIS

SPYState Street SPDR S&P 500 ETF Trust778.57 +0.60%VOOVanguard S&P 500 ETF715.59 +0.61%IVViShares Core S&P 500 ETF781.97 +0.60%RSPInvesco S&P 500 Equal Weight ETF213.04 +0.55%

BIS ETF FAQ

What is the BIS price today?

BIS last traded at $11.53 as of Oct 9, 4:00 PM EDT, down 5.68% on the day.

What is BIS's expense ratio?

BIS has an expense ratio of 0.95%, which works out to about $95.00 per year for every $10,000 invested.

Does BIS pay a dividend?

Yes. BIS has a trailing dividend yield of 5.53%.

How big is BIS?

BIS has about $1.9 million in assets under management.